Vanderbilt study tracks new lung cancer drug target
4/23/2014
Researchers at Vanderbilt University have identified a potential new drug target in subtypes of lung cancer that are difficult to treat.
FDA approves Cyramza for stomach cancer
4/23/2014
The U.S. Food and Drug Administration has approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the...
Link between chronic inflammation and 'high-grade' prostate cancer
4/23/2014
Men who show signs of chronic inflammation in non-cancerous prostate tissue may have nearly twice the risk of actually having prostate cancer than those with no inflammation, according to results of...
Link uncovered between Down syndrome and leukemia
4/23/2014
Although doctors have long known that people with Down syndrome have a heightened risk of developing acute lymphoblastic leukemia (ALL) during childhood, they haven't been able to explain why.
With gene expression analysis growing in importance for both basic researchers and medical practitioners, researchers at Carnegie Mellon University and the University of Maryland have developed a new...
The source identified of most cases of invasive bladder cancer
4/23/2014
A single type of cell in the lining of the bladder is responsible for most cases of invasive bladder cancer, according to researchers at the Stanford University School of Medicine.
Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth.
Anxiety over false-positive mammogram results is 'only temporary'
4/23/2014
The anxiety that comes with receiving a false-positive mammogram result is only temporary, researchers say, and it actually makes women more likely to undergo screening in future.
Stigma and related emotional effects experienced by lung cancer patients
4/23/2014
It's not uncommon these days to find a colored ribbon representing a disease. A pink ribbon is well known to signify breast cancer. But what color ribbon does one think of with lung cancer?
Living devices may selectively kill cancer cells without disrupting healthy cells
4/23/2014
A Northwestern synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other...